FKRCX
Price
$52.26
Change
+$0.05 (+0.10%)
Updated
Sep 11 closing price
Net Assets
3.49B
RYPMX
Price
$314.40
Change
+$1.58 (+0.51%)
Updated
Sep 11 closing price
Net Assets
135.02M
Interact to see
Advertisement

FKRCX vs RYPMX

FKRCX vs RYPMX Comparison Chart in %
View a ticker or compare two or three
VS
FKRCX vs. RYPMX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKRCX is a Hold and RYPMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FKRCX has more cash in the bank: 3.49B vs. RYPMX (135M). FKRCX pays higher dividends than RYPMX: FKRCX (9.31) vs RYPMX (2.55). FKRCX was incepted earlier than RYPMX: FKRCX (57 years) vs RYPMX (33 years). RYPMX (1.33) is less costly to investors than FKRCX (0.87). RYPMX is a more actively managed with annual turnover of: 328.00 vs. FKRCX (22.76). FKRCX has a lower initial minimum investment than RYPMX: FKRCX (1000) vs RYPMX (2500). FKRCX annual gain was more profitable for investors over the last year : 53.12 vs. RYPMX (43.35). FKRCX return over 5 years is better than : 235.87 vs. RYPMX (172.64).
FKRCXRYPMXFKRCX / RYPMX
Total Expense Ratio0.871.2868%
Annual Report Gross Expense Ratio0.871.3365%
Fund Existence57 years33 years-
Gain YTD13.15614.86089%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets3.49B135M2,587%
Annual Yield % from dividends9.312.55365%
Returns for 1 year53.1243.35123%
Returns for 3 years331.80234.73141%
Returns for 5 years235.87172.64137%
Returns for 10 years317.20225.16141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ELGAX6.090.06
+1.00%
Columbia Select Large Cap Growth A
GTDYX49.91N/A
N/A
Invesco Emerging Markets ex-China Y
VFWSX166.45N/A
N/A
Vanguard FTSE All-Wld ex-US Idx Instl
FIJDX67.08N/A
N/A
Fidelity Advisor Gold Z
BIPIX93.86N/A
N/A
ProFunds Biotechnology UltraSector Inv